Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Location
Las Vegas, NV
Fiscal year end
31 July
Latest financial report
10-Q - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3% % 51%
Return On Equity 58% % -90%
Return On Assets -1701% % -324%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99,853,763 shares 3.3%
Common Stock, Shares, Outstanding 99,853,763 shares 3.3%
Entity Public Float $1,770,764 USD -74%
Common Stock, Value, Issued $99,854 USD 3.3%
Weighted Average Number of Shares Outstanding, Basic 107,853,763 shares 3%
Weighted Average Number of Shares Outstanding, Diluted 107,853,763 shares 3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $0 USD -100%
General and Administrative Expense $769,865 USD -59%
Operating Income (Loss) $769,865 USD 44%
Net Income (Loss) Attributable to Parent $4,588,729 USD 69%
Earnings Per Share, Basic -0.04 USD/shares 73%
Earnings Per Share, Diluted -0.04 USD/shares 69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,186 USD -95%
Assets, Current $721,304 USD 566%
Assets $721,304 USD 170%
Accounts Payable, Current $1,620,079 USD 12%
Liabilities, Current $11,317,123 USD 68%
Retained Earnings (Accumulated Deficit) $66,830,907 USD -7.4%
Stockholders' Equity Attributable to Parent $10,595,819 USD -64%
Liabilities and Equity $721,304 USD 170%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $283,998 USD -14%
Net Cash Provided by (Used in) Financing Activities $290,500 USD -3.2%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 99,853,763 shares 3.3%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $616,327 USD 8476%
Interest Paid, Excluding Capitalized Interest, Operating Activities $783 USD 11%
Deferred Tax Assets, Valuation Allowance $12,453,700 USD 2.2%
Deferred Tax Assets, Gross $12,453,700 USD 2.2%
Deferred Tax Assets, Operating Loss Carryforwards $4,230,000 USD 19%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $56,135,234 USD 0.81%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,538 USD -55%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $593,864 USD -6.2%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%